Drugs Made In America Acquisition Corp. Ordinary Shares
General ticker "DMAA" information:
- Sector: Financials
- Industry: Shell Companies
- Capitalization: $234.1M (TTM average)
Drugs Made In America Acquisition Corp. Ordinary Shares follows the US Stock Market performance with the rate: 43.7%.
Estimated limits based on current volatility of 0.1%: low 10.88$, high 10.89$
Factors to consider:
- Total employees count: 2 as of 2024
- Company does not operate outside US (retrieved using AI)
Short-term DMAA quotes
Long-term DMAA plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $2.82MM |
| Operating Income | $-2.82MM |
| Non-Operating Income | $8.76MM |
| Income(Loss) | $5.94MM |
| Net Income(Loss)* | $5.94MM |
| Stockholders Equity | $-7.26MM |
| Assets | $239.92MM |
| Operating Cash Flow | $-0.54MM |
| Investing Cash Flow | $-231.15MM |
| Financing Cash Flow | $231.69MM |
| Earnings Per Share** | $0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.